Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibiotic potentiation and inhibition of cross-resistance in pathogens associated with cystic fibrosis

eLife(2023)10.7554/elife.91082Source: DataRank Database

Antibiotic potentiation and inhibition of cross-resistance in pathogens associated with cystic fibrosis is a research paper published in eLife (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)OA: goldTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

R. Christopher D. Furniss ORCID,Evgenia Maslova ORCID,Kathryn E Potter,Lara Eisaiankhongi,Patricia Bernal ORCID

Live enrichment

PubMed:42011977 PMC:PMC13099141 OpenAlex:https://openalex.org/W4387527827

Swiss National Science Foundation

Grant: 180142

Circadian Timekeepers in Proteobacteria

Academy of Medical Sciences

Grant: SBF006\1040

Cystic Fibrosis Foundation

Grant: 004846I222

Texas Biologics

Grant: TXB-24-02

Biotechnology and Biological Sciences Research Council

Grant: BB/V007823/1

Understanding the molecular survival strategies of Acinetobacter baumannii and developing strategies to disable them.

Medical Research Council

Grant: MR/Y001354/1

National Centre for the Replacement, Refinement and Reduction of Animals in Research

Grant: NC/V001582/1

Insects as models to study wound healing, infection and the wound microbiome.

MCIN/AEI/10.13039/501100011033 Spanish agency

Grant: PID2021-123000OB-I00

Swiss National Science Foundation

Grant: PZ00P3_180142

Portugal Extra Exploratory Project

Grant: 2022.15740.UTA

NIH HHS

Grant: R01AI158753

Welch Foundation

Grant: F-2250-20250403

Medical Research Council

Grant: MR/M009505/1

Characterisation of disulfide bond formation in bacterial pathogens: Unravelling the adaptation of a classical pathway into a virulence aid.

Biotechnology and Biological Sciences Research Council

Grant: BB/M011178/1

Multidisciplinary training for the Biosciences

MCIN/AEI/10.13039/501100011033 Spanish agency

Grant: RYC2019-026551-I

Wellcome Trust

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R01AI158753-04

The interplay between cell envelope protein homeostasis and antibiotic resistance in Gram-negative bacteria

goldLicense: cc-by

journalhttps://doi.org/10.7554/elife.91082

GREENhttps://github.com/elifesciences/enhanced-preprints-data/raw/master/data/91082/v1/91082-v1.pdf

publisherhttps://doi.org/10.7554/elife.91082

publisherhttps://cdn.elifesciences.org/articles/91082/elife-91082-v1.pdf

publisherhttps://cdn.elifesciences.org/articles/91082/elife-91082-v1.xml

Fields of Study

Cystic Fibrosis Research AdvancesBacterial biofilms and quorum sensingVibrio bacteria research studiesMedicineBiology0301 basic medicine03 medical and health sciencesCystic FibrosisAnti-Bacterial AgentsStenotrophomonas maltophiliaPseudomonas aeruginosaHumansDrug Resistance, BacterialDrug Resistance, Multiple, Bacterialbeta Lactam AntibioticsMicrobial Sensitivity Tests

MeSH Terms

beta Lactam AntibioticsAnti-Bacterial AgentsCystic FibrosisHumansMicrobial Sensitivity TestsPseudomonas aeruginosaPseudomonas InfectionsStenotrophomonas maltophiliaDrug Resistance, BacterialDrug Resistance, Multiple, Bacterial

Keywords

Stenotrophomonas maltophiliaPseudomonas aeruginosaAntibioticsMicrobiologyCystic fibrosisBiologyAntibiotic resistanceStenotrophomonasPathogenMultidrug toleranceLipid IIBiofilmBurkholderiaDrug resistanceBacteriaPseudomonasBacterial cell structureGeneticsE. coliInfectious diseaseAntimicrobial resistancePolymicrobial InfectionsArticle

Sustainable Development Goals

SDG 0: Good health and well-being